ARHGAP25 expression in colorectal cancer as a biomarker associated with favorable prognosis

Although progress has been made in the early diagnosis of colorectal cancer (CRC) and in the systemic therapy of patients with CRC, the prognosis for advanced CRC remains poor. Our previous study demonstrated that ARHGAP25 overexpression significantly inhibits CRC cell growth, invasion and migration...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yue, Lin, Yi, Zhu, Yingjie, Zhang, Xiaoyun, Tao, Li, Yang, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892469/
https://www.ncbi.nlm.nih.gov/pubmed/35251635
http://dx.doi.org/10.3892/mco.2022.2517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892469/
https://www.ncbi.nlm.nih.gov/pubmed/35251635
http://dx.doi.org/10.3892/mco.2022.2517

Ejemplares similares